Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Nvs    crawled date : 2021 - 12 - 22    save search

Alnylam Comments on FDA Approval of Leqvio®, the First siRNA (RNAi Therapeutic) Approved to Reduce LDL-C
Published: 2021-12-22 (Crawled : 23:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.99% C: 0.92%
ALNY | $146.06 0.19% 0.18% 540K twitter stocktwits trandingview |
Health Technology
| | O: -5.24% H: 2.44% C: -0.93%

leqvio fda fda approval approval
FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year
Published: 2021-12-22 (Crawled : 23:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.99% C: 0.92%

leqvio novartis fda cholesterol
Sandoz launches authorized generic of Narcan® (naloxone hydrochloride) Nasal Spray 4 mg in US to help reverse opioid overdose, expanding access during surge in overdose deaths
Published: 2021-12-22 (Crawled : 22:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.99% C: 0.92%

narcan nasal spray opioid authorized
Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness
Published: 2021-12-22 (Crawled : 12:30) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.99% C: 0.92%

novartis gene therapy therapeutics therapy
Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA
Published: 2021-12-22 (Crawled : 07:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.99% C: 0.92%

ema application authorization biosimilar
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.